Ernexa Therapeutics, Inc. (ERNA)
7.50
-0.32
(-4.09%)
USD |
NASDAQ |
May 08, 09:30
Ernexa Therapeutics Research and Development Expense (Annual) : 4.156M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ocular Therapeutix, Inc. | 197.10M |
| Quince Therapeutics, Inc. | 35.38M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Tango Therapeutics, Inc. | 129.88M |
| Aprea Therapeutics, Inc. | 7.043M |